Effects of nicorandil on myocardial infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: study design and protocol for the randomized controlled trial

Previous studies have shown that nicorandil has a protective effect on cardiomyocytes. However, there is no study to investigate whether perioperative intravenous nicorandil can further reduce the myocardial infarct size in patients with ST-segment elevation myocardial infarction (STEMI) compared to...

Descripción completa

Detalles Bibliográficos
Autores principales: JIANG, Xiao-Si, TIAN, Li-Chao, JIANG, Zi-Chao, ZOU, Yu-Ting, LI, Ping, YANG, Xin-Chun, SU, Xi, TIAN, Jin-Wen, SHI, Bei, LI, Zong-Zhuang, LI, Yong-Jun, YANG, Ren-Qiang, QIAN, Geng, CHEN, Yun-Dai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Science Press 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475214/
https://www.ncbi.nlm.nih.gov/pubmed/32952527
http://dx.doi.org/10.11909/j.issn.1671-5411.2020.08.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475214/
https://www.ncbi.nlm.nih.gov/pubmed/32952527
http://dx.doi.org/10.11909/j.issn.1671-5411.2020.08.002

Ejemplares similares